Skip to main content

Patients still struggle to balance high costs of MS treatment, despite generic

By NPR  
   January 20, 2020

Sometimes, the approval of a new generic drug offers more hype than hope for patients' wallets, as people with multiple sclerosis know all too well. New research shows just how little the introduction of a generic version of Copaxone — one of the most popular MS drugs — did to lower their medicine costs.

Full story

Get the latest on healthcare leadership in your inbox.